Caliper Q2 Revenues Bounce 32 Percent on Strong Research Business

CEO Kevin Hrusovsky noted the growth potential of Caliper's next-generation sequencing sample prep business and said that it may look to acquire a reagent business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories